skip to main content
Idioma:
Resultados 1 2 3 4 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover assunto: Pharmacology. Drug Treatments remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group
Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Oxaliplatin or Paclitaxel in Patients With Platinum-Pretreated Advanced Ovarian Cancer: A Randomized Phase II Study of the European Organization for Research and Treatment of Cancer Gynecology Group

PICCART, M. J ; GREEN, J. A ; VAN GLABBEKE, M ; LACOMBE, D ; PINEL, M.-C ; PECORELLI, S ; JIMENEZ LACAVE, A ; REED, N ; VERGOTE, I ; BENEDETTI-PANICI, P ; BONETTI, A ; KRISTELLER-TOME, V ; MENDIOLA FERNANDEZ, C ; CURRAN, D

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1193-1202 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
2
Dose-Dense Anthracycline-Based Chemotherapy for Node-Positive Breast Cancer
Dose-Dense Anthracycline-Based Chemotherapy for Node-Positive Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose-Dense Anthracycline-Based Chemotherapy for Node-Positive Breast Cancer

ELLIS, Georgiana K ; LIVINGSTON, Robert B ; GRALOW, Julie R ; GREEN, Stephanie J ; THOMPSON, Tove

Journal of clinical oncology, 2002-09, Vol.20 (17), p.3637-3643 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
3
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

BURRIS, H. A ; MOORE, M. J ; NELSON, R ; DORR, F. A ; STEPHENS, C. D ; VON HOFF, D. D ; ANDERSEN, J ; GREEN, M. R ; ROTHENBERG, M. L ; MODIANO, M. R ; CRIPPS, M. C ; PORTENOY, R. K ; STORNIOLO, A. M ; TARASSOFF, P

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2403-2413 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
4
American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants
American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants
Material Type:
Artigo 		Adicionar ao Meu Espaço

American Society of Clinical Oncology Clinical practice guidelines for the use of chemotherapy and radiotherapy protectants

HENSLEY, M. L ; SCHUCHTER, L. M ; NEGRIN, R ; SZATROWSKI, T. P ; THIGPEN, J. T ; VON HOFF, D ; WASSERMAN, T. H ; WINER, E. P ; PFISTER, D. G ; LINDLEY, C ; MEROPOL, N. J ; COHEN, G. I ; BRODER, G ; GRADISHAR, W. J ; GREEN, D. M ; LANGDON, R. J ; MITCHELL, R. B

Journal of clinical oncology, 1999-10, Vol.17 (10), p.3333-3355 [Periódico revisado por pares]

Baltimore, MD: Lippincott Williams & Wilkins

Sem texto completo

Citações Citado por
5
Congestive Heart Failure After Treatment for Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group
Congestive Heart Failure After Treatment for Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Congestive Heart Failure After Treatment for Wilms’ Tumor: A Report From the National Wilms’ Tumor Study Group

GREEN, Daniel M ; GRIGORIEV, Yevgeny A ; NAN, Bin ; TAKASHIMA, Janice R ; NORKOOL, Pat A ; D, Giulio J ; ANGIO ; BRESLOW, Norman E

Journal of clinical oncology, 2001-04, Vol.19 (7), p.1926-1934 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
6
Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431
Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Study of Cisplatin With Gemcitabine or Paclitaxel or Vinorelbine as Induction Chemotherapy Followed by Concomitant Chemoradiotherapy for Stage IIIB Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Study 9431

VOKES, Everett E ; HERNDON, James E ; CRAWFORD, Jeffrey ; LEOPOLD, Kenneth A ; PERRY, Michael C ; MILLER, Antonius A ; GREEN, Mark R

Journal of clinical oncology, 2002-10, Vol.20 (20), p.4191-4198 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
7
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group

CLAMON, G ; HERNDON, J ; COOPER, R ; CHANG, A. Y ; ROSENMAN, J ; GREEN, M. R

Journal of clinical oncology, 1999-01, Vol.17 (1), p.4-11 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
8
Pregnancy Outcome After Treatment for Wilms Tumor: A Report From the National Wilms Tumor Study Group
Pregnancy Outcome After Treatment for Wilms Tumor: A Report From the National Wilms Tumor Study Group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pregnancy Outcome After Treatment for Wilms Tumor: A Report From the National Wilms Tumor Study Group

GREEN, Daniel M ; PEABODY, Eve M ; NAN, Bin ; PETERSON, Susan ; KALAPURAKAL, John A ; BRESLOW, Norman E

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2506-2513 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
9
Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer
Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer

CHOI, N. C ; HERNDON, J. E ; ROSENMAN, J ; CAREY, R. W ; CHUNG, C. T ; BERNARD, S ; LEONE, L ; SEAGREN, S ; GREEN, M

Journal of clinical oncology, 1998-11, Vol.16 (11), p.3528-3536 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
10
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer

SPEYER, JL ; GREEN, MD ; ZELENIUCHJACQUOTTE, A ; WERNZ, JC ; REY, M ; SANGER, J ; KRAMER, E ; FERRANS ; HOCHSTER, H ; MEYERS, M ; BLUM, RH ; FEIT, F ; ATTUBATO, M ; BURROWS, W ; MUGGIA, FM

Journal of clinical oncology, 1992-01, Vol.10 (1), p.117-127 [Periódico revisado por pares]

PHILADELPHIA: American Society of Clinical Oncology

Sem texto completo

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.